Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Blood|November 11, 2017
FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapyAnja Mottok, Vindi Jurinovic, Pedro Farinha, et al.
Haematologica|October 15, 2020
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RASMarcel Seibold, Thorsten Stühmer, Nadine Kremer, et al.
Cancers|June 19, 2024
Functional Investigation of IGF1R Mutations in Multiple MyelomaSofia Catalina Heredia-Guerrero, Marietheres Evers, Sarah Keppler, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|March 29, 2019
High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformationJoaquim Carreras, Armando Lopez-Guillermo, Yara Yukie Kikuti, et al.
Acta Biomaterialia|July 5, 2024
A 3D bioreactor model to study osteocyte differentiation and mechanobiology under perfusion and compressive mechanical loadingWyonna Darleen Rindt, Melanie Krug, Shuntaro Yamada, et al.
Blood|November 8, 2019
Localized- and advanced-stage follicular lymphomas differ in their gene expression profilesAnnette M Staiger, Eva Hoster, Vindi Jurinovic, et al.
The Journal of Experimental Medicine|April 6, 2011
NFATc1 affects mouse splenic B cell function by controlling the calcineurin--NFAT signaling networkSankar Bhattacharyya, Jolly Deb, Amiya K Patra, et al.
Pageof 5